GMP
-
Probiogen Signs Therapeutic Protein Process Development Contract with Virdante
ProBioGen, a technology and service provider for the development and production of biopharmaceutical drug substances, has announced the signing of a contract with Virdante Biopharmaceuticals, a US-based biopharmaceutical development company. The f…
GMP | 28 May 2010
-
On the Move: Pharmaceuticals R&D in Asia (Part Four)
Different countries posses varying characteristics that affect the selection of business models for outsourcing activities.
GMP | 01 January 2010
-
Scancell: Completion of Manufacture for Cancer Vaccine
Cobra Biomanufacturing has announced that the current Good Manufacturing Practice (cGMP) production of Scancell Holdings' SCIB1 DNA vaccine has been successfully completed ahead of planned clinical trials. SCIB1 is being developed for the treatm…
GMP | 16 November 2009
-
API Manufacturing: Complying with International GMP Regulations
Asian Manufacturers of Active Pharmaceutical Ingredients (API) have to adhere to Good Manufacturing Practice (GMP) guidelines in order to penetrate Western markets.
GMP | 01 June 2009
-
ISPE Releases Document on Maintenance Good Practices
ISPE has released its Good Practice Guide on Maintenance. It provides current, established practices to help achieve technical and regulatory accuracy and cost-effective compliance. These are useful for a new program or when reviewing an existing pro…
GMP | 15 May 2009
-
Japan Workshop 2008
In early November, representatives from the Japanese and European pharmaceutical and biotech industries met in Tokyo for Japan Workshop 2008. The event was held under the banner of “Primary Packaging and Drug Delivery Trends for Injectablesâ€.…
GMP | 08 December 2008
-
GMP Trends in Asia
Asia needs a harmonized approach to GMP audits.
GMP | 01 November 2008
-
The Impact of GMP Today
Process analytical technologies could develop products in the laboratory for manufacturing while using science.
GMP | 01 October 2008
-
Accessing GMP-Grade Stem Cell Lines in Large Pharma Company
ES Cell International (ESI) has entered into an agreement with a prominent international pharmaceutical company to assess ESI’s proprietary good manufacturing practice-grade (GMP-grade) human embryonic stem cell (hESCs) lines. The pharmaceutic…
GMP | 01 October 2008
-
Diapharm starts GMP audit service for active pharmaceutical ingredients
Pharma service provider Diapharm is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs). In a shared audit several medicinal product manufacturers jointly commission the check of production conditions fo…
GMP | 18 September 2008
